ECTRIMS 2024: Simvastatin fails to gradual incapacity development in SPMS
Day by day remedy with high-dose simvastatin, a broadly used cholesterol-lowering drugs, didn’t gradual incapacity development in adults with secondary revolutionary illness or SPMS, in step with top-line knowledge from a Segment